Summit Partners Announces Growth Investment in Dreampath Diagnostics
Summary
Summit Partners made a growth investment in Dreampath Diagnostics to help the company expand globally and scale its operations. Dreampath builds digital sample management software and related traceability solutions for anatomical pathology laboratories. The platform automates tissue sample archiving and retrieval, reduces manual errors, and improves turnaround times for labs. The company says it already manages more than 250 million samples across more than 500 labs in nearly 40 countries. Both Summit representatives joined Dreampath’s board as part of the transaction.
Funding
Amount
-
Total raised
Date
July 14, 2025
Announcement date
Investors
Summit Partners
Lead investors
Company
https://www.dreampathdx.net
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected